Two small-cap biotech names made serious noise today. Xenon Pharmaceuticals (XENE) is trading at $62.76, up 49.6% today, while Relmada Therapeutics (RLMD) sits at $7.17, also up 61.1% Both moves were ...
From quartz sand to silicon wafers, the manufacturing process is critical for achieving the purity and quality needed for ...
ZeroRISC, the transparent silicon supply chain integrity company, today announced the full open-source release of its cryptographic hardware and software stack for both classical and post-quantum ...
Whether you're looking for a good budget pair of noise-canceling headphones or an expensive set for premium sound, these are ...
AMD is widening its embedded roadmap in a way that feels very deliberate, very timely, and frankly rather aggressive. The Ryzen AI Embedded P100 series is no longer just about compact edge compute ...
DT Research, a U.S. leader in precision-engineered computing solutions designed for mission-critical and demanding environments, today announced the unveiling of the DT573 and DT556 All-in-One (AIO) ...
About one in three Americans who use CBD say they take it as an alternative or supplement to at least one ...
Rising NEC Incidence: The global increase in diagnosed cases of neuroendocrine tumors (including carcinomas) is a major market growth driver. This uptick is driven by better detection and reporting, ...
The modern educational experience is a clear example of how mismatched today's world is from ancestral conditions.
The BNY Mellon Equity Income Fund returned 2.86% in Q4 2025, outperforming its S&P 500 benchmark. Read the full analysis for more details.
Researchers have found in a new study that among men with prostate cancer undergoing androgen deprivation therapy, use of oxybutynin 5 mg twice daily significantly reduced the frequency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results